Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8+ responses in HIV type 1-infected patients: Comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy

Journal of Virology

Volumn 73, Issue 9, 1999, Pages 7108-7116

  Dalod, Marc ^a,b   Dupuis, Marion ^a   Deschemin, Jean Christophe ^a   Sicard, Didier ^b   Salmon, Dominique ^b   Delfralssy, Jean Francois ^c   Venet, Alain ^a   Sinet, Martine ^a   Guillet, Jean Gerard ^a  

^a INSTITUT COCHIN   (France)

^b Hôpital Cochin ^*  (France)

^c BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTOSIS; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REPLICATION;

EID: 0032837971     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.9.7108-7116.1999     Document Type: Article

References (44)

1. Altman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94-96.
2. Bariou, C., N. Genetet, A. Ruffault, C. Michelet, F. Cartier, and B. Genetet. 1997. Longitudinal study of HIV-specific cytotoxic T lymphocyte in HIV type 1 infected patients; relative balance between host immune response and the spread of HIV type 1 infection. AIDS Res. Hum. Retroviruses 13:1301-1312.
3. Binley, J. M., X. Jin, Y. Huang, L. Zhang, Y. Cao, D. D. Ho, and J. P. Moore. 1998. Persistent antibody response but declining cytotoxic T-lymphocyte responses to multiple human immunodeficiency virus type 1 antigens in a long-term nonprogressing individual with a defective p17 proviral sequence and no detectable viral RNA expression. J. Virol. 72:3472-3474.
4. Borrow, P., H. Lewicki, X. Wei, M. S. Horwitz, N. Peffer, H. Meyers, J. A. Nelson, J. E. Gairin, B. H. Hahn, M. B. A. Oldstone, and G. M. Shaw. 1997. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 3:205-211.
5. Bourgault, I., A. Gomez, E. Gomard, and J. P. Levy. 1991. Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes. Clin. Exp. Immunol. 84:501-507.
6. Brander, C., P. J. R. Goulder, K. Luzuriaga, O. O. Yang, K. E. Hartman, N. G. Jones, B. D. Walker, and S. A. Kalams. 1999. Persistent HIV-1-specific CTL clonal expansion despite high viral burden post in utero HIV-1 infection. J. Immunol. 162:4796-4800.
7. Brinchman, J. E., J. H. Dobloug, B. H. Heger, L. L. Haaheim, M. Sannes, and T. Egeland. 1994. Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations. J. Infect. Dis. 169:730-738.
8. + T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp. Med. 187:1395-1402.
9. Carmichael, A., X. Jin, and P. Sissons. 1996. Analysis of the human env-specific cytotoxic T-lymphocyte (CTL) response in natural human immunodeficiency virus type 1 infection: low prevalence of broadly cross-reactive env-specific CTL. J. Virol. 70:8468-8476.
10. Carmichael, A., X. Jin, P. Sissons, and L. Borysiewicz. 1993. Quantitative analysis of the human immunodeficiency virus type 1 response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177:249-256.
11. + cell counts: correlations with various parameters of disease progression. AIDS Res. Hum. Retroviruses 12:497-506.
12. Dalod, M., M. Harzic, I. Pellegrin, B. Dumon, B. Hoen, D. Sereni, J.-C. Deschemin, J.-P. Levy, A. Venet, and E. Gomard. 1998. Evolution of cytotoxic T lymphocyte responses to HIV-1 in patients with symptomatic primary infection on antiretroviral triple therapy. J. Infect. Dis. 178:61-69.
13. + T cells of HIV-seropositive patients. Eur. J. Immunol. 29:38-44.
14. + lymphocyte activity. J. Infect. Dis. 172:329-339.
15. + T cell levels: results of 6 years of follow-up. J. Acquired Immune Defic. Syndr. 6:904-912.
16. Goulder, P., D. Price, M. Nowak, S. Rowland-Jones, R. Phillips, and A. McMichael. 1997. Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses. Immunol. Rev. 159:17-29.
17. Greenough, C., M. Somasundaran, D. B. Brettler, R. M. Hesselton, A. Alimenti, F. Kirchhoff, D. Panicali, and J. L. Sullivan. 1994. Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retroviruses 4:395-403.
18. Greenough, T. C., D. B. Brettler, M. Somasundaran, D. L. Panicali, and J. L. Sullivan. 1997. Human immunodeficiency virus type-1-specific cytotoxic T lymphocytes, virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo. J. Infect. Dis. 176:118-125.
19. Haas, G., U. Plikat, P. Debré, M. Lucchiari, C. Katlama, Y. Dudoit, O. Bonduelle, M. Bauer, H.-G. Ihlenfeldt, G. Jung, B. Maier, A. Meyerhans, and B. Antran. 1996. Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo. J. Immunol. 157:4212-4221.
20. HIV Molecular Immunology Database, http://hiv-web.lanl.gov/immuno/index. [Online.]
21. + cytotoxic cells express CD38 and HLA-DR antigens. J. Immunol. 150:3070-3079.
22. Hoffenbach, A., P. Langlade-Demoyen, G. Dadaglio, E. Vilmer, F. Michel, C. Mayaud, B. Autran, and F. Plata. 1989. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J. Immunol. 142:452-462.
23. Kalams, S. A., R. P. Johnson, A. K. Trocha, M. J. Dynan, H. S. Ngo, R. T. D'Aquila, J. T. Kurnick, and B. D. Walker. 1994. Longitudinal analysis of T cell receptor (TCR) genes usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179:1261-1271.
24. Kersten, M. J., M. R. Klein, A. M. Holwerda, F. Miedema, and M. H. J. van Oers. 1997. Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection. Different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma. J. Clin. Investig. 99:1525-1533.
25. Koup, R. A., C. A. Pikora, K. Luzuriaga, D. B. Brettler, E. S. Day, G. P. Mazzara, and J. L. Sullivan. 1991. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities. J. Exp. Med. 174:1593-1600.
26. Kuroda, M. J., J. E. Scmitz, D. H. Barouch, A. Craiu, T. M. Allen, A. Sette, D. I. Watkinc, M. A. Forman, and N. L. Letvin. 1998. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class-I-peptide complex. J. Exp. Med. 187:1373-1381.
27. + memory T cells. J. Exp. Med. 186:859-865.
28. + T lymphocytes specific for Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 95:270-275.
29. Lamhamedi-Cherradi, S., B. Culmann-Penciolelli, B. Guy, M.-P. Kieny, F. Dreyfus, A.-G. Saimot, D. Sereni, D. Sicard, J.-P. Levy, and E. Gomard. 1992. Qualitative and quantitative analysis of human cytotoxic T-lymphocyte responses to HIV-1 proteins. AIDS 6:1249-1258.
30. + anti-HIV lymphocytes in the control of HIV infection. Antibiot. Chemother. 48:13-20.
31. Liebermann, J., J. A. Fabry, M. C. Kuo, P. Earl, B. Moss, and P. R. Skolnik. 1992. Cytotoxic T lymphocytes from HIV-1 seropositive individuals recognize immunodominant epitopes in Gp160 and reverse transcriptase. J. Immunol. 148:2738-2747.
32. Lubaki, N. M., S. C. Ray, B. Dhruva, T. C. Quinn. R. F. Siliciano, and R. C. Bollinger. 1997. Characterization of a polyclonal cytolytic T lymphocyte response to human immunodeficiency virus in persons without clinical progression. J. Infect. Dis. 175:1360-1367.
33. Matano, T., R. Shibata, C. Siemon, M. Connors, M. C. Lane, and M. A. Martin. 1998. Administration of an anti-CD8 monoclonal antibody interferes with viral clearance of the chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J. Virol. 72:164-169.
34. MHCPEP Database. gopher://wehll.wehi.edu.au:70/77/MHCPEP.DB. [Online.]
35. Moss, P. A., S. Rowland-Jones, P. M. Frodsham, S. McAdam, P. Giangrandes, A. McMichael, and J. I. Bell. 1995. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in the peripheral blood of infected donors. Proc. Natl. Acad. Sci. USA 92:5773-5777.
36. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. D. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177-187.
37. Ogg, G. S., X. Jin, S. Bonhoeffer, P. R. Dunbar, M. A. Nowak, S. Monard, J. P. Segal, Y. Cao, S. L. Rowland-Jones, V. Cerundolo, A. Hurley, M. Markowitz, D. D. Ho, D. F. Nixon, and A. J. McMichael. 1998. Quantitation of HTV-1-specific cytotoxic T lymphocytes and plasma viral load RNA. Science 279:2103-2106.
38. Pantaleo, G., J. F. Demarest, T. Schacker, M. Vaccarezza, O. J. Cohen, M. Dauchcr, C. Graziosi, S. S. Schnittman, T. C. Quinn, G. M. Shaw, L. Perrin, G. Tambussi, A. Lazzarin, R. P. Sekaly, H. Soudeyns, L. Corey, and A. S. Fanci. 1997. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc. Natl. Acad. Sci. USA 94:254-258.
39. Pontesilli, O., M. R. Klein, S. R. Kerkhof-Garde, N. G. Pakker, F. de Wolf, H. Schuitemaker, and F. Miedema. 1998. Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: a predominant gag-specific response is associated with nonprogressive infection. J. Infect. Dis. 178:1008-1018.
40. Rinaldo, C. R., L. A. Belz, X-L. Huang, P. Gupta, Z. Fan, and D. J. Torpey. 1995. Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men. AIDS Res. Hum. Retroviruses 11:481-489.
41. Safrit, J. T., C. A. Andrews, T. Zhu, D. D. Ho, and R. A. Koup. 1994. Characterization of human immunodeficiency virus type-1 specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope. J. Exp. Med 179:463-472.
42. Scheibenbogen, C., K.-H. Lee, S. Stevanovic, M. Witzens, M. Willhauck, V. Waldmann, H. Naeher, H.-G. Rammensee, and U. Keilholz. 1997. Analysis of the T cell response to tumor and viral peptide antigens by an IFN-γ ELISPOT assay. Int. J. Cancer 71:932-936.
43. + lymphocytes. Science 283:857-860.
44. Trimble, L. A., and J. Lieberman. 1998. Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3zeta, the signaling chain of the T-cell receptor complex. Blood 91:585-594.